Solid Draft Guidance Propels Evoke
Shares of Evoke Pharma rose in the market on Tuesday in the wake of solid draft guidance for its Phase 3 study.
Shares of Evoke Pharma rose in the market on Tuesday in the wake of solid draft guidance for its Phase 3 study.
The U.S. Department of Agriculture indicated that the corn crop for this year faces some hurdles, and that has pushed up the spot price for a gallon of ethanol.
Investors appear to be less than impressed with the taste of earnings that Sonic gave them on Tuesday morning.
The latest report on U.S. business inventories showed a slight rise in the month of July, right in line with expectations.
Sientra has filed with the U.S. Securities and Exchange Commission (SEC) to update the terms for its secondary offering.
Shifting to stocks with better upside potential makes sense as it is a very good bet that the volatility index will stay elevated for some time to come.
The U.S. Federal Reserve has announced its reading on industrial production and capacity utilization for the month of August.
GW Pharmaceuticals is making great strides in the field of medicine with its most recent trial of Cannabidiol in patients with schizophrenia.
The U.S. Air Force awarded contracts to three contending teams of contractors angling for a deal to replace the 16 Joint Surveillance Target Attack Radar Systems (JSTARS) planes currently in the fleet.
The August U.S. retail sales report was positive but mixed, when you take the revisions for July into consideration.
After a very negative August reading, the Empire State Manufacturing report for September was almost as ugly, as well as way short of estimates.
Approximately 9 million mortgaged properties had positive equity below 20% at the end of the second quarter.
While not always the best strategy in the world, owning what the top portfolio managers have in their funds is a way to let some of the best minds in the industry do the…
Xenoport made waves in Tuesday morning’s premarket trading session on news of positive clinical trial results.
The European Central Bank says that the recovery of housing prices in the eurozone has not been particularly robust so far, but prices are moving up across several of the region's members.